| Current advances and trends in the treatment of depression P Blier, C De Montigny Trends in pharmacological sciences 15 (7), 220-226, 1994 | 1481 | 1994 |
| Differences between males and females in rates of serotonin synthesis in human brain S Nishizawa, C Benkelfat, SN Young, M Leyton, S Mzengeza, ... Proceedings of the national academy of sciences 94 (10), 5308-5313, 1997 | 1161 | 1997 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological … SH Kennedy, RW Lam, RS McIntyre, SV Tourjman, V Bhat, P Blier, ... The Canadian Journal of Psychiatry 61 (9), 540-560, 2016 | 1092 | 2016 |
| Serotonin receptor 1A knockout: an animal model of anxiety-related disorder S Ramboz, R Oosting, DA Amara, HF Kung, P Blier, M Mendelsohn, ... Proceedings of the National Academy of Sciences 95 (24), 14476-14481, 1998 | 1020 | 1998 |
| Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted, M Van Ameringen, ... BMC psychiatry 14, 1-83, 2014 | 909 | 2014 |
| Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists F Artigas, L Romero, C de Montigny, P Blier Trends in neurosciences 19 (9), 378-383, 1996 | 843 | 1996 |
| Autoregulation of serotonin neurons: role in antidepressant drug action G Piñeyro, P Blier Pharmacological reviews 51 (3), 533-591, 1999 | 708 | 1999 |
| Is there a role for 5-HT1A agonists in the treatment of depression? P Blier, NM Ward Biological psychiatry 53 (3), 193-203, 2003 | 696 | 2003 |
| Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines A Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, ... Journal of Psychopharmacology 29 (5), 459-525, 2015 | 678 | 2015 |
| Monoamine neurocircuitry in depression and strategies for new treatments M Hamon, P Blier Progress in Neuro-Psychopharmacology and Biological Psychiatry 45, 54-63, 2013 | 627 | 2013 |
| Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression P BLIER, C de MONTIGNY, Y CHAPUT Journal of clinical psychopharmacology 7 (6), 24S, 1987 | 581 | 1987 |
| Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain P Blier, C De Montigny Synapse 1 (5), 470-480, 1987 | 566 | 1987 |
| The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments R Mongeau, P Blier, C De Montigny Brain Research Reviews 23 (3), 145-195, 1997 | 519 | 1997 |
| Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial EJ Daly, MH Trivedi, A Janik, H Li, Y Zhang, X Li, R Lane, P Lim, AR Duca, ... JAMA psychiatry 76 (9), 893-903, 2019 | 440 | 2019 |
| A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. P Blier, C de Montigny, Y Chaput The Journal of clinical psychiatry 51, 14-20; discussion 21, 1990 | 431 | 1990 |
| Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression P Blier, R Bergeron Journal of clinical psychopharmacology 15 (3), 217-222, 1995 | 430 | 1995 |
| Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors N Haddjeri, P Blier, C de Montigny Journal of Neuroscience 18 (23), 10150-10156, 1998 | 429 | 1998 |
| Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study P Blier, HE Ward, P Tremblay, L Laberge, C Hébert, R Bergeron American Journal of Psychiatry 167 (3), 281-288, 2010 | 420 | 2010 |
| Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain Y Chaput, C de Montigny, P Blier Naunyn-Schmiedeberg's archives of pharmacology 333, 342-348, 1986 | 414 | 1986 |
| Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function L Santarelli, G Gobbi, PC Debs, EL Sibille, P Blier, R Hen, MJS Heath Proceedings of the National Academy of Sciences 98 (4), 1912-1917, 2001 | 373 | 2001 |
